Biocon Biologics completely acquires Viatris’s global biosimilars business
Biocon Biologics will recognise the combined revenue and associated profits from the acquired collaboration biosimilars with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Akums enters into joint association with Leiutis and Biophore to bring first-of-its-kind…
The partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value…
Gland Pharma enters into a Put Option Agreement to acquire 100 per cent of Cenexi Group
The proposed acquisition remains subject to receipt of necessary regulatory approvals and satisfaction of certain conditions
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US
The licensing pact has been inked between Evive and Acrotech Biopharma (Acrotech), a New Jersey-based and wholly-owned subsidiary…
South Africa’s Biovac in new Oral Cholera Vaccine deal
The partnership with non-profit IVI, headquartered in South Korea, aims to boost output and reduce vaccine shortages amid a spate…
Sun Pharma and SPARC enter into licence agreement for commercialisation of phenobarbital for…
Product awaiting the US FDA approval, targetted at treating seizures in neonatal patients
Pharma industry reports 79 M&A deals in October 2022
The industry reported 102 Venture Capital (VC) deals worth $1.8 billion in October 2022, compared to the last 12-month average…
Akums Drugs ties up with Microcore Research to manufacture NESM supplements for healthy joints
With this tie-up, Akums will leverage NESM and develop dietary supplements for maintaining healthy joint and connective tissues
Lupin signs agreement to acquire two inhalation brands from Sunovion
The company expects the transaction to be accretive to earnings in the first year
Marksans acquires capacity from Tevapharm India
The transaction is in cash consideration, and is expected to be finalised by 1st April, 2023, subject to the usual closing…
Grifols in 15-year deal with Canada for plasma-based medicines
Under the agreement, Grifols, which uses blood plasma to make medicines, will work with Canadian Blood Services (CBS) to also…
Lupin and DKSH sign exclusive licensing and supply agreement to market five biosimilar candidates in…
According to the agreement, Lupin’s subsidiary in Philippines, Multicare Pharma, will file for marketing approval and be…
Pharma deals value decreases by 14.8 per cent in August 2022: GlobalData
The industry reported 120 Venture Capital (VC) deals worth $2.6 billion in August 2022, compared to the last 12-month average…
Sonde Health inks multi-year partnership with Koye Pharma
Strategic partnership created to develop and license a new vocal biomarker detection and monitoring capability for COPD in India
Swiss eye-care firm Alcon to buy Aerie Pharma for about $753 million
The deal will add Aerie's Rocklatan and Rhopressa eye drops, along with a pipeline of many clinical and pre-clinical ophthalmic…
Roche Pharma India and SKCC, USA launch ACMO in India for oncologists/pathologists
One-of-its-kind programme to train more than 100 cancer specialists, pathologists in personalised medicine
Indoco launches initiative to promote green energy
This is in compliance with the regulatory requirement for being a ‘captive user’, under the Indian Electricity laws
Gerresheimer and Zollner enter into strategic partnership for electronically controlled medtech…
The two companies tap into growing demand for digital and connected drug delivery and diagnostic systems
CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs
Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs
AstraZeneca completes acquisition of TeneoTwo
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100 million